Spain

Following rapid growth earlier in the decade, the Spanish medical devices reached an estimated value of US$3.9bn in 2007. Although the market is still expanding at a brisk pace in... 2008-02-13

Meanwhile, a public listing should prove a boon to the Spanish pharmaceutical industry and could result in similar action for a spate of other drug firms. In June 2007, leading indigenous... 2007-12-21

The Spanish Society of Oncological Medicine (SEOM) claims that even though treatment standards are among the highest in Europe, the country still needs greater investment cancer research,... 2007-11-15

Spain's Ministry of Health (MoH) is reportedly hesitant to promote biosimilars - generic copies of biotechnology drugs - due to concerns that they do not have bioequivalency to the... 2007-11-01

Pharmamar, a subsidiary of Spanish drugmaker Zeltia , has announced that its cancer drug Yondelis (trabectedin) has gained European Union (EU) approval.

A number of Norwegian municipalities are running rehabilitation centres for the elderly in the Alicante region of Spain, where land is cheaper and the climate is beneficial to the... 2007-06-27

The Spanish Ministry of Health has announced that it will reimburse most new oncology drugs approved by the European Medicines Agency (EMEA), after recent studies suggested that there... 2007-05-03

With developments such as the Barcelona Science Park and the Biomedical Research Park, Catalonia has long been the hub of pharmaceutical research in Spain. The recent creation of... 2007-05-01

Spain's drug market is set to be strongly affected by the introduction of a new reference pricing system on March 1st 2007. Under the new structures, branded drugs and generic equivalents... 2007-01-25

Among other strategies, pharmaceutical companies are considering reducing their presence in Spain after the new regulation that lowers governmental reimbursement for several pharmaceutical... 2007-01-05